University of Florida Transplant Hepatology

Topics

• Hepatitis C virus research 168
• Liver Diseases and Immunity 162
• Liver Disease Diagnosis and Treatment 60
• Hepatocellular Carcinoma Treatment and Prognosis 38
• Liver Disease and Transplantation 37
• Protease and Inhibitor Mechanisms 18
• Hepatitis B Virus Studies 16
• Porphyrin Metabolism and Disorders 15
• Organ Transplantation Techniques and Outcomes 13
• Gallbladder and Bile Duct Disorders 9
• Microbial bioremediation and biosurfactants 8
• Sepsis Diagnosis and Treatment 8

Most cited

1. Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

   The New England journal of medicine · 2024 · 257 citations · Cynthia Levy

2. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.

   The New England journal of medicine · 2024 · 236 citations · Cynthia Levy

3. Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

   The lancet. Gastroenterology & hepatology · 2026 · 28 citations · Cynthia Levy

4. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.

   Hepatology (Baltimore, Md.) · 2022 · 207 citations · Ghassan Hammoud

5. Primary biliary cholangitis: Epidemiology, prognosis, and treatment.

   Hepatology communications · 2023 · 128 citations · Cynthia Levy

6. Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

   Journal of hepatology · 2026 · 24 citations · Cynthia Levy